In a new filing with the Securities and Exchange Commission, Bain Capital's Brookside Capital disclosed increasing its activist stake in PTC Therapeutics, Inc. (NASDAQ:PTCT).
Keep Reading →
October 16 - Hedge Funds, News
As a new filing with the Securities and Exchange Commission showed today, Samuel Isaly's Orbimed Advisors have trimmed its exposure to Relypsa Inc (NASDAQ:RLYP).
Keep Reading →
September 19 - Hedge Funds, News
Scopia Capital Management has disclosed in a recent regulatory filing with the Security and Exchange Commission that it has acquired 4.2 million shares of Aegerion Pharmaceuticals...
Keep Reading →
August 12 - Hedge Funds, News
As a new form 4 filing with the Securities and Exchange Commission showed, Julian and Felix Bakers' Baker Bros Advisors, a fund focused on the biotechnology and healthcare companies...
Keep Reading →
June 25 - Hedge Funds, News
Over the past week, a few multi millionaire insider purchases caught my eye.
Keep Reading →
June 10 - Hedge Funds, Insider Trading
Peter Kolchinsky's hedge fund, Ra Capital Management disclosed upping its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) some more.
Keep Reading →
November 22 - Hedge Funds, News
RA Capital, Achillion Pharmaceuticals: In a 13G filing with the SEC, Peter Kolchinsky's RA Capital disclosed that it owns nearly 15% of infectious disease-focused biopharma player...
Keep Reading →
October 4 - Hedge Funds, News
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, ...
Keep Reading →
September 9 - News
Now, according to many investors, hedge funds are seen as delayed, outdated financial tools of an era lost to time.
Keep Reading →
September 4 - News
In the eyes of many traders, hedge funds are perceived as useless, outdated financial vehicles of a period lost to current times.
Keep Reading →
September 3 - News
In the 21st century investor’s toolkit, there are plenty of metrics investors can use to monitor publicly traded companies.
Keep Reading →
September 3 - News
To the average investor, there are many gauges shareholders can use to analyze the equity markets. Some of the most innovative are hedge fund and insider trading activity.
Keep Reading →
September 2 - News
If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles of a period lost to current times.
Keep Reading →
August 30 - News
To the average investor, there are dozens of indicators market participants can use to analyze their holdings.
Keep Reading →
August 30 - News
If you were to ask many traders, hedge funds are assumed to be overrated, old investment tools of an era lost to time.
Keep Reading →
August 30 - News
In the 21st century investor’s toolkit, there are many gauges shareholders can use to track their holdings.
Keep Reading →
August 30 - News
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age.
Keep Reading →
August 29 - News
If you were to ask many investors, hedge funds are viewed as delayed, outdated investment vehicles of an era lost to time.
Keep Reading →
August 29 - News
To many traders, hedge funds are perceived as delayed, outdated investment vehicles of an era lost to time.
Keep Reading →
August 28 - News
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies.
Keep Reading →
August 28 - News
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age.
Keep Reading →
August 28 - News
In the 21st century investor’s toolkit, there are tons of metrics shareholders can use to track publicly traded companies.
Keep Reading →
August 26 - News
In the 21st century investor’s toolkit, there are many indicators market participants can use to watch stocks.
Keep Reading →
August 26 - News
In the financial world, there are dozens of gauges shareholders can use to analyze stocks. Two of the most under-the-radar are hedge fund and insider trading sentiment.
Keep Reading →
August 26 - News
To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time.
Keep Reading →
August 25 - News
In the financial world, there are many metrics shareholders can use to track their holdings. A duo of the most innovative are hedge fund and insider trading movement.
Keep Reading →
August 23 - News
Now, according to many investors, hedge funds are viewed as delayed, old investment tools of a period lost to current times.
Keep Reading →
August 21 - News
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was in 9 hedge funds' portfolio at the end of the first quarter of 2013.
Keep Reading →
June 21 - News
In the 21st century investor’s toolkit, there are many methods shareholders can use to watch Mr. Market.
Keep Reading →
June 14 - News
